Affordable Insulin Act of 2019
- Last Action
- 3/1/2019
Actions
- 2019-03-01Referred to the Subcommittee on Health.
- 2019-02-28Referred to the House Committee on Energy and Commerce.
- 2019-02-28Introduced in House
- 2019-02-28Introduced in House
CRS Summary
As of 2019-02-28 (00)
Affordable Insulin Act of 2019
This bill addresses the importation of insulin from Canada and other foreign countries.
The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain insulin from Canada. The FDA may also permit the importation of insulin from certain other countries under specified circumstances.
The bill also establishes a process for certifying licensed foreign pharmacies and foreign wholesale distributors.
Cosponsors (1)
- Francis Rooney (R-FL)
Subjects
- Administrative law and regulatory procedures
- Canada
- Congressional oversight
- Department of Health and Human Services
- Digestive and metabolic diseases
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Government studies and investigations
- Prescription drugs
- Trade restrictions
- User charges and fees
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.